logo
  

AZN : Imfinzi + Tremelimumab With Chemotherapy Show OS Benefit In Non-small Cell Lung Cancer Trial

AstraZeneca said that a POSEIDON Phase III trial demonstrated a significant and clinically meaningful overall survival benefit for Imfinzi plus tremelimumab with chemotherapy in metastatic non-small cell lung cancer compared to chemotherapy alone.

The company said that the immunotherapy combination also demonstrated a statistically significant improvement in progression-free survival (PFS) versus chemotherapy alone.

The Imfinzi plus chemotherapy arm demonstrated a statistically significant improvement in PFS versus chemotherapy in the previous analysis, but the overall survival trend observed in this analysis did not achieve statistical significance.

According to the company, each combination demonstrated an acceptable safety profile, and no new safety signals were identified. The combination with tremelimumab delivered a broadly similar safety profile to the Imfinzi and chemotherapy combination and did not lead to an increased discontinuation of treatment.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cuisine Solutions is recalling its JUST Egg flavored plant-based "bites" products due to undeclared allergens, the U.S. Food and Drug Administration said. The recall involves a limited number of 2-pouch retail packages that may contain an incorrect sealed pouch containing whole-egg and milk products, known allergens. Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023.
Follow RTT